Annual report pursuant to Section 13 and 15(d)

2. Summary of Significant Accounting Policies: Research and Development Costs (Policies)

v3.6.0.2
2. Summary of Significant Accounting Policies: Research and Development Costs (Policies)
12 Months Ended
Sep. 30, 2016
Policies  
Research and Development Costs

Research and Development Costs

All expenditures for research and development are charged to expense as incurred.  Research and development expenses for fiscal years 2016 and 2015 were $248,441 and $106,526, respectively.  The Company expects to continue investing in research and development as it develops new products and platforms for Chronic Illness Monitoring and as funds become available.